Behind every fungal-derived medicine lies a long scientific journey that begins long before a molecule reaches the laboratory. Nature still holds thousands of undiscovered solutions, and fungi stand out for producing an enormous diversity of bioactive compounds with potential applications in human health. To obtain these bioactive compounds, selecting fungi with therapeutic potential is key.
At Hifas Biologics, we explore this potential, starting in soils, forests, and under-researched or extreme environments where fungi have developed unique survival strategies. These adaptations generate original molecules that can become new therapeutic tools to address current medical challenges.
WHAT WE LOOK FOR IN FUNGI
The selection of species is not random but follows well-defined scientific criteria. First, traditional medicinal use is taken into account, since ethnomycology and ancestral knowledge provide a valuable starting point. When a species has been used for centuries in certain cultures, it signals that it may contain bioactive compounds of interest. We also consider isolated or extreme habitats, because fungi growing in places such as high mountains, volcanic soils, or marine environments must synthesize special metabolites to adapt, increasing the likelihood of discovering novel molecules. Finally, special attention is given to biological activity observed in vitro, analyzing strains that show antimicrobial, antifungal, or antiviral properties under laboratory conditions, as this is an initial indicator of their therapeutic potential.
A RIGOROUS PROCESS
To select fungi with therapeutic potential, the process begins with species selection. Once identified, we follow a thorough protocol that ensures every candidate is evaluated with maximum rigor. The first step is isolation, which involves the precise identification and cultivation of the fungal strain under controlled conditions to guarantee purity and reproducibility, followed by extraction, a process that allows us to obtain compounds through specific techniques that separate bioactive molecules from fungal biomass.
With the extracts prepared, we then perform biological screening — laboratory tests designed to measure the activity of each sample against different pathogenic microorganisms or in cellular models. This stage is essential to identify the compounds that demonstrate true therapeutic potential.
Finally, therapeutic validation takes place, where the safety, efficacy, and mechanisms of action of the most promising molecules are evaluated. This entire process integrates knowledge of biotechnology, mycology, and computational analysis — disciplines that accelerate the discovery of new drug candidates and maximize the potential of fungi.
ANTIMICROBIAL RESISTANCE
Antimicrobial resistance (AMR) is advancing faster than pharmaceutical innovation, posing a global health threat: common infections may become difficult or even impossible to treat. Yet in the face of this crisis, exploring the fungal world is not just a scientific opportunity but a necessity.
Fungi have interacted with bacteria, viruses, and other microorganisms for millions of years, developing a chemical arsenal to defend and adapt. Harnessing these molecules could provide unprecedented solutions to fight superbugs and open new avenues in immunology or supportive therapies.
At Hifas Biologics, we believe the potential of fungi is key to a healthier and more sustainable future. This is why the careful selection of fungi with therapeutic potential is essential. Every strain and compound discovered brings us closer to new therapies. The next generation of medicines may be waiting in remote forests, in marine soils, or even beneath our feet. Our mission is to find them, study them, and put them at the service of global health.